臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jen chang ko"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 76-100 / 290 (共12頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-03-11T08:34:30Z	The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells	Jen-Chang Ko;Wang L.-H.;Jhan J.-Y.;Ciou S.-C.;Hong J.-H.;Lin S.-T.;Lin Y.-W.; JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:30Z	The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells	Jen-Chang Ko;Wang L.-H.;Jhan J.-Y.;Ciou S.-C.;Hong J.-H.;Lin S.-T.;Lin Y.-W.; JEN-CHANG KO; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:30Z	Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Ciou S.-C.;Jhan J.-Y.;Cheng C.-M.;Su Y.-J.;Chuang S.-M.;Lin S.-T.;Chang C.-C.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:30Z	Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Ciou S.-C.;Jhan J.-Y.;Cheng C.-M.;Su Y.-J.;Chuang S.-M.;Lin S.-T.;Chang C.-C.;Lin Y.-W.; JEN-CHANG KO; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:30Z	Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells	Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:30Z	Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells	Jen-Chang Ko;Hong J.-H.;Wang L.-H.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Jheng M.-Y.;Lin Y.-W.; JEN-CHANG KO; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:29Z	Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation	Chen R.-S.;Jhan J.-Y.;Su Y.-J.;Lee W.-T.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Chuang S.-M.;Jen-Chang Ko;Lin Y.-W.; Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:29Z	Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation	Chen R.-S.;Jhan J.-Y.;Su Y.-J.;Lee W.-T.;Cheng C.-M.;Ciou S.-C.;Lin S.-T.;Chuang S.-M.;Jen-Chang Ko;Lin Y.-W.; Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:29Z	Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:29Z	Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:28Z	Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine	Jen-Chang Ko ;Tsai M.-S. ;Kuo Y.-H. ;Chiu Y.-F. ;Weng S.-H. ;Su Y.-C. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:28Z	Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine	Jen-Chang Ko ;Tsai M.-S. ;Kuo Y.-H. ;Chiu Y.-F. ;Weng S.-H. ;Su Y.-C. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:28Z	Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:28Z	Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2	Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:27Z	Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells	Jen-Chang Ko;Tsai M.-S.;Weng S.-H.;Kuo Y.-H.;Chiu Y.-F.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:27Z	Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells	Jen-Chang Ko;Tsai M.-S.;Weng S.-H.;Kuo Y.-H.;Chiu Y.-F.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:27Z	Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells	Jen-Chang Ko;Tsai M.-S.;Chiu Y.-F.;Weng S.-H.;Kuo Y.-H.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:27Z	Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells	Jen-Chang Ko;Tsai M.-S.;Chiu Y.-F.;Weng S.-H.;Kuo Y.-H.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:26Z	Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells	JEN-CHANG KO; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Huang Y.-C.; Chen H.-J.; Syu J.-J.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:26Z	Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells	JEN-CHANG KO; Huang Y.-C.; Chen H.-J.; Tseng S.-C.; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Weng S.-H.; Chiou R.Y.Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:26Z	HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells	Jen-Chang Ko;Chen H.-J.;Huang Y.-C.;Tseng S.-C.;Weng S.-H.;Wo T.-Y.;Huang Y.-J.;Chiu H.-C.;Tsai M.-S.;Chiou R.Y.Y.;Lin Y.-W.; JEN-CHANG KO; Chen H.-J.; Huang Y.-C.; Tseng S.-C.; Weng S.-H.; Wo T.-Y.; Huang Y.-J.; Chiu H.-C.; Tsai M.-S.; Chiou R.Y.Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:26Z	HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells	Jen-Chang Ko;Chen H.-J.;Huang Y.-C.;Tseng S.-C.;Weng S.-H.;Wo T.-Y.;Huang Y.-J.;Chiu H.-C.;Tsai M.-S.;Chiou R.Y.Y.;Lin Y.-W.; JEN-CHANG KO; Chen H.-J.; Huang Y.-C.; Tseng S.-C.; Weng S.-H.; Wo T.-Y.; Huang Y.-J.; Chiu H.-C.; Tsai M.-S.; Chiou R.Y.Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:25Z	Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012	Lee M.-R.;Wang H.-C.;Yang C.-Y.;Lin C.-K.;Kuo H.-Y.;Jen-Chang Ko;Sheng W.-H.;Lee L.-N.;Yu C.-J.;Hsueh P.-R.; MENG-RUI LEE; Wang H.-C.; Yang C.-Y.; CHING-KAI LIN; HAN-YUEH KUO; JEN-CHANG KO; Sheng W.-H.; Lee L.-N.; Yu C.-J.; Hsueh P.-R.
臺大學術典藏	2021-03-11T08:34:25Z	Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012	Lee M.-R.;Wang H.-C.;Yang C.-Y.;Lin C.-K.;Kuo H.-Y.;Jen-Chang Ko;Sheng W.-H.;Lee L.-N.;Yu C.-J.;Hsueh P.-R.; MENG-RUI LEE; Wang H.-C.; Yang C.-Y.; CHING-KAI LIN; HAN-YUEH KUO; JEN-CHANG KO; Sheng W.-H.; Lee L.-N.; Yu C.-J.; Hsueh P.-R.
臺大學術典藏	2021-03-11T08:34:25Z	Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells	Chen R.-S.; JEN-CHANG KO; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Chen H.-J.; Huang Y.-C.; Jian Y.-J.; Lee W.-T.; Lin Y.-W.

顯示項目 76-100 / 290 (共12頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51950194 線上人數 : 800 教育部委託研究計畫計畫執行:國立臺灣大學圖書館